PDGF Interactions: Alcohol, Caffeine, Food and Other Compounds in the Literature

Platelet-derived growth factor (PDGF) refers to a family of dimeric signalling proteins — PDGF-AA, -AB, -BB, -CC and -DD — that act through the receptor tyrosine kinases PDGFRα and PDGFRβ. Research interest spans blood-vessel biology, pericyte behaviour, fibroblast activation, wound repair, cartilage and retinal cell maintenance. Because PDGF is a protein studied mostly in cells, tissues and animal models, the question of how it might "interact" with everyday exposures such as alcohol, caffeine, meals or fasting has a short evidentiary answer: with the partial exception of alcohol, those pairings have not been formally studied in the literature indexed here.

This page summarises what the verified studies actually examined. Where no interaction study exists, that is stated plainly, and the mechanistic reasoning researchers typically apply is described and labelled as reasoning, not as a finding. This page is for educational purposes only and is not medical advice; consult a licensed physician for any questions about health, medications or research participation.

PDGF and Alcohol: What Studies Report

Alcohol is the one lifestyle exposure in this family with a directly relevant human measurement. A clinical study of platelet-derived growth factor C in alcoholics examined circulating PDGF-C in people with alcohol use disorder, reporting on this growth factor in the context of chronic alcohol consumption (PMID 31897468). That work measured an endogenous ligand concentration in a drinking population; it did not administer PDGF to anyone, and it did not test whether alcohol changes the activity of PDGF given as an intervention.

That distinction matters when interpreting the term "interaction". Researchers who measure a circulating growth factor in a population with a particular exposure are asking whether the exposure associates with altered levels of the endogenous protein (PMID 31897468). They are not asking whether the exposure modifies the pharmacology of an administered compound. No study in this verified set combined alcohol exposure with exogenous PDGF administration in either animals or humans.

Mechanistic reasoning researchers apply (labelled as reasoning, not evidence)

PDGF ligands and receptors are studied extensively in fibrotic and vascular remodelling contexts, and the liver is a classic site of both alcohol injury and PDGF-driven stellate cell biology. Investigators therefore frame alcohol and PDGF as plausibly convergent on shared tissue pathways. This is a framing hypothesis. It is not supported by an experiment in the verified literature on this page, and no directional claim — increase, decrease, potentiation or blunting — can be drawn from it.

PDGF and Caffeine: No Direct Interaction Study Identified

No study in the verified set examined caffeine, coffee, tea, energy drinks or other methylxanthines in combination with PDGF ligands or PDGFR signalling. There is no reported effect to summarise, in either direction.

What the literature does document is the intracellular machinery PDGF engages, which is where any mechanistic speculation would have to land. A quantitative phosphoproteomics study characterised the phosphorylation landscape downstream of PDGF stimulation and identified collapsin response mediator protein 2 as a participant in PDGF-induced cell migration (PMID 28638064). Studies of this kind map kinase-level events; they do not test dietary stimulants, and nothing in that phosphoproteomic work addressed caffeine (PMID 28638064).

Reasoning, labelled as such: caffeine is often discussed in relation to cyclic-nucleotide and adenosine-receptor signalling, and PDGFR activation triggers broad downstream phosphorylation cascades. A theoretical point of convergence can be drawn on paper. No published experiment in this set tested it, so the honest summary is that the interaction is unstudied.

PDGF, Food, Meals and Fasting

No study in the verified set examined fed versus fasted states, meal timing, macronutrient composition or caloric restriction in relation to PDGF ligands or receptor signalling. PDGF proteins are studied in cell culture, tissue preparations and animal models where nutritional state is generally a controlled background variable rather than the experimental question.

Metabolic context does appear indirectly in one line of work. A study of PDGF-D activation by macrophage-derived urokinase plasminogen activator examined angiotensin II–induced cardiac remodelling in obese mice, placing PDGF-D within an obesity-associated cardiac phenotype (PMID 34236404). That study used obesity as a disease model background, not as a dietary intervention tested against PDGF administration (PMID 34236404). It reported on proteolytic activation of a PDGF ligand by an enzyme released from macrophages, which is a biochemical mechanism rather than a nutritional one.

Combinations That Have Been Studied

The published "combination" literature for PDGF is biological rather than dietary. Several studies paired PDGF ligands with cells, inhibitory domains or receptor partners and reported what changed.

PDGF-BB with adipose-derived stem cells

A preclinical study combined PDGF-BB with adipose-derived stem cells and reported accelerated wound healing with modulation of the PTEN/AKT pathway (PMID 37028952). Researchers in that work treated the combination as the experimental variable, which is the structure a genuine interaction study takes: each component alone, then together, with an outcome measured against both.

Prodomain as a differential inhibitor

A molecular study reported that the PDGF-D prodomain differentially inhibited the biological activities of PDGF-D and PDGF-B, indicating that an endogenous protein fragment can suppress ligand activity unequally across family members (PMID 35777468). The study described a protein-level inhibitory relationship rather than a small-molecule or dietary one.

Co-receptor binding

Another study reported that neuropilin-1 binds PDGF-D and acts as a co-receptor in PDGF-D–PDGFRβ signalling (PMID 28254885). Findings of this type explain why the same ligand can behave differently in different tissues: the available co-receptors and partner proteins differ.

Pathway-level combinations in disease models

A study targeting PDGF signalling in cancer-associated fibroblasts reported that this blocked feedback activation of HIF-1α and tumour progression in clear cell ovarian cancer models (PMID 38670097). Separately, researchers reported that PDGF-BB inhibited F-actin formation and chondrocyte dedifferentiation in osteoarthritis through oxygen-dependent HIF-1α/SCIN regulation and inhibition of RhoA/ROCK signalling (PMID 41135736). Both described interactions between PDGF signalling and other intracellular pathways, which is a different category from the substance-combination questions that motivate most interaction searches.

Context: What PDGF Studies Have Reported Overall

Understanding the interaction gap is easier against the backdrop of what PDGF research has covered. Investigators reported that skeleton-secreted PDGF-BB mediated arterial stiffening, linking a bone-derived source of the ligand to vascular mechanics (PMID 34437300). In the nervous system, researchers reported that endothelial PDGF-D contributed to neurovascular protection after ischaemic stroke by rescuing pericyte functions (PMID 38769116). In the retina, a study reported that PDGF receptor alpha signalling was key for Müller cell homeostasis functions (PMID 33503976). A further paper examined PDGF-D–induced immunoproteasome activation and cell–cell interactions using computational and structural approaches (PMID 37066124).

Across that body of work, the experimental systems were cells, tissues and animals, and the manipulated variables were ligands, receptors, genes and pathways — not beverages, meals or supplements (PMID 34437300, PMID 38769116). That design choice is the direct explanation for why substance-interaction data are thin.

Adverse Events and Combination Risks: What Studies Report

The verified studies on this page were mechanistic and preclinical in design and did not report structured adverse-event tables from human administration of PDGF combined with alcohol, caffeine or food. The human data point available described measurement of PDGF-C in people with alcohol use disorder rather than tolerability of an administered agent (PMID 31897468).

Some studies did report biology that researchers interpret as context-dependent. PDGF signalling in cancer-associated fibroblasts was reported to drive feedback activation of HIF-1α and tumour progression in ovarian cancer models, with inhibition of that signalling blocking progression (PMID 38670097). Researchers also reported that PDGF-D activation by macrophage-derived uPA promoted angiotensin II–induced cardiac remodelling in obese mice (PMID 34236404). These are findings about pathological signalling in disease models, reported as observations, and they are described here without any inference about outcomes in people.

How to Read an "Interaction" Claim

• Direct interaction study: both substances present, factorial design, outcome measured. The PDGF-BB plus adipose-derived stem cell wound study is structured this way (PMID 37028952).
• Association study: an exposure group is compared on a biomarker, as with PDGF-C measurement in alcoholics (PMID 31897468). Association does not establish that the exposure alters an administered compound.
• Background condition: a metabolic or disease state provides the model, as in the obese-mouse cardiac remodelling work (PMID 34236404). The condition is not the tested intervention.
• Mechanistic extrapolation: two pathways plausibly converge, but nobody ran the experiment. Most claims about PDGF with caffeine or fasting fall here.

Open Questions in the Literature

1. Whether chronic alcohol exposure alters PDGF ligand levels causally, beyond the association reported in a drinking population (PMID 31897468).
2. Whether nutritional or fasting states change PDGFR-driven phosphorylation events of the kind mapped in phosphoproteomic work (PMID 28638064).
3. Whether co-receptor availability, such as neuropilin-1 binding to PDGF-D, varies with systemic metabolic conditions (PMID 28254885).
4. Whether endogenous inhibitory fragments such as the PDGF-D prodomain are modulated by external exposures (PMID 35777468).

Until such studies appear, the accurate statement is that the interaction literature for PDGF with alcohol, caffeine and diet is limited to one observational human measurement and a body of mechanistic work that did not test these exposures. This page is educational only and is not medical advice; a licensed physician is the appropriate source for individual health questions.

References

• Platelet-Derived Growth Factor C in Alcoholics (Alcohol and Alcoholism, 2020)
• Quantitative Phosphoproteomics Reveals a Role for Collapsin Response Mediator Protein 2 in PDGF-Induced Cell Migration (Scientific Reports, 2017)
• PDGF-D activation by macrophage-derived uPA promotes AngII-induced cardiac remodeling in obese mice (Journal of Experimental Medicine, 2021)
• Combination of PDGF-BB and adipose-derived stem cells accelerated wound healing through modulating PTEN/AKT pathway (Injury, 2023)
• PDGF-D Prodomain Differentially Inhibits the Biological Activities of PDGF-D and PDGF-B (Journal of Molecular Biology, 2022)
• Neuropilin 1 binds PDGF-D and is a co-receptor in PDGF-D-PDGFRβ signaling (Journal of Cell Science, 2017)
• Targeting PDGF signaling of cancer-associated fibroblasts blocks feedback activation of HIF-1α and tumor progression of clear cell ovarian cancer (Cell Reports Medicine, 2024)
• PDGF-BB inhibits F-actin formation and chondrocyte dedifferentiation in osteoarthritis via oxygen-dependent HIF-1α/SCIN regulation and RhoA/ROCK signaling inhibition (European Journal of Pharmacology, 2025)
• Skeleton-secreted PDGF-BB mediates arterial stiffening (Journal of Clinical Investigation, 2021)
• Endothelial PDGF-D contributes to neurovascular protection after ischemic stroke by rescuing pericyte functions (Cellular and Molecular Life Sciences, 2024)
• PDGF Receptor Alpha Signaling Is Key for Müller Cell Homeostasis Functions (International Journal of Molecular Sciences, 2021)
• PDGF-D-induced immunoproteasome activation and cell-cell interactions (Computational and Structural Biotechnology Journal, 2023)